Grünenthal USA celebrates opening of new office in Morristown
October 7, 2015 Grünenthal USA, Inc. recently celebrated the opening of its new office space in Morristown, New Jersey. Executive board members including Alberto Grua, Chief Commercial Officer, and Klaus Langner, Chief Scientific Officer, from Grünenthal GmbH joined local CEO, Sascha Mielcarek during the ribbon cutting ceremony.
Grünenthal USA is a subsidiary of Grünenthal GmbH, an independent, family-owned pharmaceutical company specializing in pain management. Grünenthal USA partners with other leading pharmaceutical companies to deliver innovative products to patients living with pain. Current activities include partnering of Grünenthal’s proprietary abuse deterrent formulation technology (INTAC®) and clinical development of innovative pain therapy treatments.
Grünenthal USA has been in New Jersey since 2003 and was formerly located in Bedminster, NJ. The new office space signals a long-term commitment of the company to stay in New Jersey and to specifically be located in the fast-growing Morristown area.
The Grünenthal Group is present in 32 countries with affiliates in Europe, Australia, Latin America and the US. Grünenthal products are sold in more than 155 countries and approx. 5,300 employees are working for the Grünenthal Group worldwide. In 2014, Grünenthal achieved revenues of € 1.154 bn. More information: www.grunenthal.com.